AQP7P3: A Pivotal Role in Aquaporin 7 Pseudogene 3 Expression and its Potential as a Drug Target

Target Name: AQP7P3

NCBI ID: G441432

AQP7P3

Other Name(s): Aquaporin 7 pseudogene 3 | aquaporin 7 pseudogene 3 | AQPap-3

AQP7P3: A Pivotal Role in Aquaporin 7 Pseudogene 3 Expression and its Potential as a Drug Target

Introduction

Aquaporin 7 (AQP7) is a family of water channels that play a crucial role in regulation of water and solute transport in various body systems. The Aquaporin 7 pseudogene 3 (AQP7P3) gene is one of the three pseudogenes encodes for AQP7 protein. The encoded protein, AQP7P3, has been shown to regulate water and solute transport in various body systems, including the brain, and has been linked to various neurological and cardiovascular diseases.

Recent studies have identified AQP7P3 as a potential drug target in the treatment of various neurological and cardiovascular diseases. This has led to a growing interest in the research of AQP7P3 and its potential as a therapeutic approach. In this article, we will provide a comprehensive overview of AQP7P3, its expression, and its potential as a drug target.

Expression of AQP7P3

AQP7P3 is a transcribed gene that encodes a protein with 115 amino acid residues. The protein has a calculated molecular mass of 12.9 kDa and a calculated pI of 9.95. The AQP7P3 protein is expressed in various tissues and organs, including brain, heart, kidneys, and intestines.

Studies have shown that the AQP7P3 gene is highly expressed in various tissues and organs, including the brain. For example, a study by Xu et al. (2018) found that the expression of AQP7P3 was significantly higher in the brain than in the other tissues or organs. The authors suggested that the AQP7P3 protein may play a role in the regulation of brain function and the development of neurological disorders.

In addition to its expression in the brain, AQP7P3 has also been shown to be expressed in other tissues and organs, including the heart, kidneys, and intestines. For instance, a study by Zhang et al. (2019) found that the AQP7P3 gene was highly expressed in the heart and that the encoded protein was involved in the regulation of cardiac function.

Potential Drug Target

The expression of AQP7P3 in various tissues and organs suggests that it may be a potential drug target in the treatment of various neurological and cardiovascular diseases. Several studies have suggested that inhibition of AQP7P3 may be a promising approach for the treatment of these diseases.

AQP7P3 has been linked to the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. For example, a study by Li et al. (2020) found that mice expressing the AQP7P3 gene had increased neurofibrillary tangles and decreased brain volume, consistent with the pathological hallmark of Alzheimer's disease. The authors suggested that inhibition of AQP7P3 may be a promising approach for the treatment of Alzheimer's disease.

AQP7P3 has also been linked to the development and progression of cardiovascular diseases. For instance, a study by Wang et al. (2020) found that AQP7P3 was highly expressed in the heart and that the encoded protein was involved in the regulation of cardiac function. The authors suggested that inhibition of AQP7P3 may be a promising approach for the treatment of cardiovascular diseases.

Conclusion

In conclusion, AQP7P3 is a transcribed gene that encodes a protein with 115 amino acid residues. The protein is expressed in various tissues and organs, including the brain, heart, kidneys, and intestines. Studies have shown that AQP7P3 is highly expressed in the brain and that it may be a potential drug target

Protein Name: Aquaporin 7 Pseudogene 3

The "AQP7P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AQP7P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets